Nearly 30% of patients with mesial temporal lobe epilepsy (TLE) are resistant to treatment with antiepileptic drugs. Neural stem cell (NSC) grafting into the hippocampus could offer an alternative therapy to hippocampal resection in these patients. As TLE is associated with reduced numbers of inhibitory gamma-amino butyric acid (GABA)-ergic interneurons and astrocytes expressing the anticonvulsant glial-derived neurotrophic factor (GDNF) in the hippocampus, we tested the hypothesis that grafting of NSCs that are capable of adding new GABA-ergic interneurons and GDNF-expressing astrocytes into the epileptic hippocampus restrains spontaneous recurrent motor seizures (SRMS) in chronic TLE. We grafted NSCs expanded in vitro from embryonic medial ganglionic eminence (MGE) into hippocampi of adult rats exhibiting chronic TLE with cognitive impairments. NSC grafting reduced frequencies of SRMS by 43% and stage V seizures by 90%. The duration of individual SRMS and the total time spent in seizures were reduced by 51 and 74%, respectively. Grafting did not improve the cognitive function however. Graft-derived cells (equivalent to 28% of injected cells) were observed in various layers of the epileptic hippocampus where they differentiated into NeuN1 neurons (13%), S-100b1 astrocytes (57%), and NG21 oligodendrocyte-progenitors (3%). Furthermore, among graft-derived cells, 10% expressed GABA and 50% expressed GDNF. Additionally, NSC grafting restored GDNF in a vast majority of the hippocampal astrocytes but had no effect on neurogenesis. Thus, MGE-NSC therapy is efficacious for diminishing SRMS in chronic TLE. Addition of new GABA-ergic neurons and GDNF1 cells, and restoration of GDNF in the hippocampal astrocytes may underlie the therapeutic effect of MGE-NSC grafts.
INTRODUCTION
Epilepsy affects >50 million people worldwide [1] . Temporal lobe epilepsy (TLE), typified by complex partial seizures and hippocampal neurodegeneration, is seen in 30% of epileptic patients [2] . Seizures in TLE are associated with memory impairments [3, 4] and reduced hippocampal neurogenesis [5] [6] [7] . Nearly 35% of patients with TLE exhibit seizures that cannot be controlled by antiepileptic drugs [8] . Although surgical resection of the hippocampus gives better seizure control, this option is associated with cognitive impairments [9] , loss of viable tissue during resection and the possibility of continuing dependence on anticonvulsant drugs after resection [10] . Thus, alternative treatment modalities that are efficient for controlling spontaneous recurrent motor seizures (SRMS) in chronic TLE are needed.
As the occurrence of seizures in TLE is thought to be linked partially to reduced numbers of hippocampal GABAergic interneurons [11, 12] and loss of functional inhibition [13, 14] , the idea of restraining SRMS via grafting of cells that release GABA has received attention [15] . Indeed, grafting of fetal GABA-ergic cells and immortalized GABA-producing cells reduces seizures in epilepsy models [15] [16] [17] [18] . Nevertheless, clinical application of these cell types is difficult because of the nonavailability of adequate amounts of cells, ethical issues concerning fetal cells [19] and the inability of GABAþ fetal/immortalized cells to have more than transient effects even with sustained GABA-ergic expression in some epilepsy models [15, 20, 21] . In this context, cell types that are capable of providing an unlimited source of donor cells, giving rise to significant numbers of GABA-ergic neurons and secreting anticonvulsant proteins such as the glial-derived neurotrophic factor (GDNF; [22] ) appear useful. Grafting of such cells might engender a sustained anticonvulsant effect over prolonged periods of time through both strengthening of the GABA-ergic circuitry and anticonvulsant actions of GDNF secreted by them.
Neural stem cells (NSCs) from the embryonic medial ganglionic eminence (MGE) appear ideal as donor cells for grafting in epilepsy, as they can be expanded in culture and have the ability to give rise to GABA-ergic interneurons. Moreover, because MGE is the region in the embryonic brain that generates most of the hippocampal GABA-ergic neurons [23, 24] , MGE-NSC derived GABA-ergic neurons might incorporate better into the epileptogenic hippocampal circuitry. Additionally, as NSC-derived cells express multiple neurotrophic factors including GDNF [25] , NSC grafting could lead to both additions of new cells that synthesize GDNF and restorative effects on cell types in the epileptic host hippocampus. Therefore, we examined whether grafting of NSCs that are capable of adding new GABA-ergic interneurons and GDNFexpressing cells into the epileptic hippocampus would restrain SRMS in chronic TLE. We bilaterally grafted NSCs expanded in vitro from the embryonic MGE into hippocampi of rats exhibiting chronic TLE with learning and memory impairments and measured: (a) changes in the frequency and intensity of SRMS, (b) learning and memory function, (c) survival and differentiation of graft-derived cells, (d) addition of GABA-ergic neurons and GDNFþ cells from grafts, and (e) effects of grafting on the number of GDNFþ astrocytes and neurogenesis in the hippocampus. This investigation represents the first study that quantified the efficacy of intrahippocampal NSC grafting for restraining spontaneous seizures in a model of chronic TLE.
MATERIALS AND METHODS

Animals and Induction of Status Epilepticus
A flowchart summary of the entire experimental design is shown in Figure 1 . Young adult (5 months old) Fischer 344 rats were treated with graded intraperitoneal injections of kainic acid (3.0 mg/kg/hour) to induce status epilepticus (SE), as detailed in our previous reports [26, 27] . The motor seizures during SE were scored according to the modified Racine scale [28] and the procedure is described in the Supporting Information.
Selection of Chronically Epileptic Rats for Grafting Studies
Although all rats that undergo SE develop chronic epilepsy characterized by SRMS, the extent of SRMS varies considerably between animals [26, 27] . Therefore, a group of age-matched chronically epileptic animals exhibiting a similar extent of SRMS (n ¼ 11) were chosen from a larger pool of animals that were chronically epileptic for prolonged periods (see Supporting Information for details). This was accomplished via measuring the average frequencies of all SRMS and stage V seizures, the average Figure 1 . Experimental design illustrating the creation of host rats with chronic epilepsy for grafting and sham-grafting surgery (on the left side), and the preparation of fresh NSCs expanded in vitro from embryonic MGE as donor cells (upper half on right). The various measurements performed after MGE-NSC grafting include frequency, duration and severity of spontaneous seizures, learning and memory function, graft cell survival and differentiation, and effects of grafts on expression of GDNF in hippocampal astrocytes (lower half on right). Abbreviations: EGF, epidermal growth factor; FGF-2, fibroblast growth factor-2; GABA, gamma-amino butyric acid; GDNF, glial-derived neurotrophic factor; MGE, medial ganglionic eminence; NSC, neural stem cell; SRMS, spontaneous recurrent motor seizures. duration of individual SRMS, and the total time spent in seizures over 4 weeks through direct observation. The observation and scoring was done in two 4-hour sessions per week for four consecutive weeks before their selection for the grafting study.
Analyses of Learning and Memory Function in Chronically Epileptic Rats Before Grafting
All chronically epileptic animals chosen for grafting (n ¼ 11) were next subjected to water maze testing for ascertaining the spatial learning and memory function before grafting. For comparison, age-matched naïve control rats (n ¼ 6) were also included for water maze testing. The rats were trained to find the platform submerged in the water using spatial cues in 11 learning sessions (four trials per session) followed by a probe test at 24 hours after the last training session [29] . Rats were released from different locations in the four quadrants to ensure that hippocampal dependent learning is measured [30] . A full description of the water maze testing used is available in the Supporting Information.
Harvesting, Expansion, and Labeling of MGE-NSCs In Vitro
Embryonic day 14 (E14) fetuses were removed from deeply anesthetized timed pregnant F344 rats by cesarean section and collected in a culture medium [27] . The methods used for the expansion of NSCs as neurospheres and the labeling of neurosphere cells with chlorodeoxyuridine (CldU; an analog of 5 0 -bromodoxyuridine) are described in the Supporting Information. The neurospheres were collected, mechanically dissociated and the cell suspension was sieved through a filter with a pore size of 40 lm. The cells were washed three to four times in a fresh culture medium through centrifugation, viability assessed through a trypan blue exclusion test, and the concentration of viable cells was adjusted to a density of 80,000 cells/l per microliter in a differentiation medium comprising Neurobasal, B-27 with retinoic acid, and L-glutamine. Only cell suspensions that exhibited 75% viability were used for grafting. The CldU labeling index in each cell suspension was determined by CldU immunostaining after an overnight incubation of dissociated cells in poly-L-lysine-coated 35-mm culture dishes containing the differentiation medium described above. Only cell suspensions that exhibited 91% CldU labeling index were used in grafting studies. As cells were grafted shortly after adding the differentiation medium, NSCs were not given time to differentiate before transplantation.
Analyses of the Differentiation Potential of MGE-NSCs In Vitro
The MGE-NSCs, prepared using methods that are described above for grafting, were plated onto the poly-L-lysine-coated 35-mm culture dishes containing the differentiation medium (as above) and incubated for 4-8 days at 37 C with 5% CO 2 [31] . The cultures were fixed with 2% paraformaldehyde and processed for different single/dual immunofluorescence assays for identifying: (a) neurons expressing b-III tubulin (TuJ-1), (b) astrocytes expressing glial fibrillary acidic protein (GFAP), (c) immature oligodendrocytes expressing the protein O1, and (d) inhibitory interneurons expressing GABA, using methods described in our earlier reports [31, 32] .
Grafting of MGE-NSCs into Hippocampi of Chronically Epileptic Rats
Two months after the water maze testing, chronically epileptic rats (n ¼ 9) were grafted with MGE-NSCs. Of the 11 chronically epileptic rats tested for water maze, two rats were excluded due to a self-mutilation injury, as per the animal protocol guidelines. Eight grafts were placed into hippocampi of each rat (i.e., four grafts per hippocampus) using methods detailed in our earlier reports [27, 32, 33] and in the Supporting Information.
Measurement of Postgrafting SRMS and Analyses
Changes in the extent of SRMS were measured for 3 months after grafting. This comprised measurement of the average frequencies of all SRMS and stage V seizures, the average duration of individual SRMS, and the total time spent in seizures over 3 months through direct observation. The observation and scoring was done in two 4-hour sessions per week for 3 months (i.e., 96 hours of observation over 12 weeks). Of the nine rats that received grafting, one rat died within 24 hours after the grafting due to postoperative complications and two rats died of unknown cause at 1-2 months after grafting. Cumulative pregrafting seizure scores were then compared with postgrafting seizure scores for every month using repeated measures analysis of variance (ANOVA) for the six animals that survived the entire experimental period.
Analyses of Learning and Memory Function After Grafting
Two months after grafting, all surviving grafted animals (n ¼ 6) underwent a second water maze test. The methods and analyses are identical to the first water maze test and are described in the Supporting Information.
Analyses of the Effects of Sham-Grafting Surgery
To determine whether grafting surgery itself has any effects on SRMS, we analyzed changes in the frequency and duration of SRMS in an additional group of chronically epileptic rats exhibiting a similar extent of SRMS (n ¼ 6) with sham-grafting surgery involving injections of the culture medium. Presham-grafting seizure scores were then compared with postsham-grafting seizure scores for every month using repeated measures ANOVA.
Analyses of the Yield and Differentiation of Graft-Derived Cells
All surviving grafted rats (n ¼ 6) were perfused with 4% paraformaldehyde, brain tissues were collected and 30-lm thick sections were cut coronally through the hippocampus using a cryostat and collected serially [26, 27] . Every 10th section was processed for CldU immunostaining using anti-CldU from Serotech and the BrdU immunostaining protocol described in our previous report [34] . Transplants in five hippocampi (from five different grafted animals) were analyzed for the yield of graft-derived cells. Cells positive for CldU were counted through the entire anterior-posterior extent of the hippocampus using the optical fractionator counting method in Stereo Investigator system (Microbrightfield, Inc., Williston, VT). The stereological counting procedure used is detailed in our earlier reports [25, 27, 34] . Since four transplants (each comprising 80,000 live cells) were placed in each hippocampus, analyses of the yield of graft-derived cells from five hippocampi are equivalent to characterization of the yield from 20 transplants. The overall yield of graft-derived cells in each hippocampus was expressed as the percentage of injected cells (i.e., 320,000 live cells).
Differentiation of graft-derived cells into NeuNþ mature neurons, S-100bþ mature astrocytes, NG2þ oligodendrocyte progenitors, GABAþ inhibitory interneurons, and cells expressing GDNF were determined from five distinct transplants from five animals. For this, we performed dual immunofluorescence assays for CldU and NeuN, CldU and S-100b, CldU and NG2, CldU and GABA, CldU and GDNF, and confocal microscopic analyses of individual dual labeled cells using 1-lm thick optical Z-stacks, as described in our previous report [25] . The primary antibodies used were anti-CldU from Serotech, anti-NeuN, anti-NG2, anti-S100b, and anti-GDNF from Chemicon, and anti-GABA from Sigma. The secondary antibodies used were anti-rat IgG or antimouse IgG conjugated to Alexa Fluor 488 or 594, biotinylated anti-rat or anti-mouse IgG, streptavidin Texas Red, and streptavidin fluorescein from Molecular Probes. Separate sets of 50-100 CldUþ cells from each of the five transplants were examined for each of the five neural cell markers using Z-section analyses in a confocal microscope (LSM-510, Zeiss) for obtaining percentages of NeuNþ neurons, S-100bþ astrocytes, NG2þ oligodendrocyte progenitors, GABAþ inhibitory interneurons, and cells expressing GDNF among graft-derived cells.
Analyses of the Effects of MGE-NSC Grafts on GDNF1 Astrocytes in the Epileptic Hippocampus
As chronic epilepsy is associated with decreased numbers of hippocampal astrocytes expressing GDNF and GDNF has anticonvulsant properties, we examined whether MGE-NSC grafting improves the extent of hippocampal astrocytes expressing GDNF. We quantified and compared the percentages of astrocytes expressing GDNF in three different groups of rats: age-matched naïve controls (n ¼ 4), rats with chronic epilepsy alone (n ¼ 4), and chronically epileptic rats that received MGE-NSC grafts (n ¼ 4). For this, we performed dual immunofluorescence assay for S-100b and GDNF (using primary antibodies from Chemicon) and analyzed the fractions of S-100bþ astrocytes expressing GDNF in the dentate gyrus, and the CA1 and CA3 subfields of the hippocampus using Z-section analyses in a confocal microscope (LSM-510, Zeiss). In every animal belonging to the three groups, an average of 204 S-100bþ cells in the hippocampus were examined for GDNF expression using Z-section analyses in a confocal microscope (i.e., 816 S-100bþ cells per each of the three groups).
Analyses of the Effects of MGE-NSC Grafts on Hippocampal Neurogenesis
As chronic epilepsy is associated with substantially declined hippocampal neurogenesis [5] [6] , we examined whether MGE-NSC grafting improves the status of hippocampal neurogenesis using immunostaining of serial sections (every 15th) through the grafted hippocampus for doublecortin (a marker of newly born immature neurons [35] ). The protocols used for doublecortin (DCX) immunostaining has been described in our previous reports [5, 25, 35] . We quantified the total number of DCXþ neurons in the dentate subgranular zone and the granule cell layer (SGZ-GCL) of chronically epileptic rats that received MGE-NSC grafts (n ¼ 5) using stereological methods and compared these numbers with age-matched naïve control rats (n ¼ 5) and rats with chronic epilepsy alone (n ¼ 5).
RESULTS
MGE-NSCs Are Multipotent and Have Ability to Give Rise to GABA-ergic Neurons in Culture
Differentiation of MGE-NSCs in culture revealed the ability of these cells to give rise to all three central nervous system phenotypes: neurons, oligodendrocytes, and astrocytes ( Fig. 2A1-2C1 , 2E1-2F2). Dual labeling analyses with TuJ-1 and GABA antibodies revealed that many neurons derived from MGENSCs express GABA (Fig. 2D1-2E2 ). After 4 days of incubation in the differentiation medium, 11% of MGE-NSCs differentiated into TuJ-1þ neurons, 15% into O1þ oligodendrocytes, and 5.8% into GFAPþ astrocytes (Fig. 2G1) . Furthermore, 70% of TuJ-1þ neurons expressed GABA (Fig. 2G1) . After 8 days of incubation, most cells had differentiated (Tuj-1, 32%; GABA, 15%; O1, 50%; and GFAP, 5%; Fig. 2H1 ).
MGE-NSC Grafting into Hippocampi of Chronically Epileptic Rats Eases SRMS
Transplantation of MGE-NSCs considerably reduced SRMS frequency, duration, and severity over the observed time-frame of 3 months. In comparison with the pretransplantation score, SRMS frequency steadily declined each month and was significantly reduced during the third month (43% reduction, p < .01; Fig. 3A) . The duration of individual SRMS underwent a decline in the first month and exhibited 51% decline in the third month after grafting (p < .05; Fig. 3B ). The overall severity of SRMS, as measured by the frequency of stage V seizures, exhibited 90% decline in the third month after grafting (Fig.  3C) . Furthermore, no stage V seizures were recorded during the second month after transplantation (Fig. 3C) . The total time spent in seizures per month (for the observation period of 32 hours) displayed 74% decrease during the third month after grafting (p < .01; Fig. 3D ). Thus, MGE-NSC grafting resulted in considerable reductions in all parameters of SRMS.
Sham-Grafting Surgery in Chronically Epileptic Rats Has No Effect on SRMS
Comparison of pre-and postsham grafting seizure scores in this group revealed that the transplantation surgery itself has no effect on major parameters of chronic epilepsy, as animals that underwent sham-grafting surgery did not show decreases in either seizure frequency or duration of individual SRMS ( Fig. 3E-3F ).
MGE-NSC Grafting Does Not Improve Learning and Memory Function in Chronically Epileptic Rats
Analyses of chronically epileptic rats before grafting with water maze testing revealed the existence of impairments in the hippocampal-dependent learning and memory function, in comparison with age-matched control rats (Fig. 4A, 4B ). Although chronically epileptic rats exhibited some ability for learning over 11 sessions as indicated by linear regression analysis and significant decrease in latency to reach the hidden platform between the first and 11th sessions, their overall performance was much inferior to control animals (Fig. 4A, 4B) . Furthermore, the probe test conducted at 24 hours after the last training session revealed impairments in memory encoding and retrieval ability. This was evidenced by much greater latencies to reach the platform area, and considerable reductions in platform area crossings, dwell times in the platform area and the platform quadrant, in comparison with control animals (Fig.  4C-4F ). In the second water maze test performed at 2 months postgrafting, rats exhibited erratic learning, as evidenced by no linear regression in latencies to reach the hidden platform and no significant decrease in latency to reach the hidden platform between the first and 11th sessions (Fig. 4A, 4B) . Overall, their post-transplantation learning scores were inferior to their pretransplantation learning scores. The probe test revealed inability for memory retention in these rats, as also observed before grafting. The overall probe test scores were statistically similar to their pretransplantation scores (Fig. 4C-4E) . Thus, MGE-NSC grafting did not improve the hippocampal-dependent learning and memory function in chronically epileptic rats.
Transplanted MGE-NSCs Survive Grafting into the Chronically Epileptic Hippocampus
Analyses of brain tissues with CldU immunostaining revealed the presence of graft-derived cells in hippocampi after 3 months of grafting. Although most graft cores were located in or attached to the CA3 region, a minority of transplant cores partially extended ventrally into the adjoining thalamus (Fig.  5A1-5A11 ). However, graft-derived cells migrated mostly into different strata (strata oriens, pyramidale, and radiatum) of the CA3 region and the lateral ends of the CA1 and dentate gyrus (DG) regions (Fig. 5A1-5A11, 5B1-5B3 ). Some migrated graft-derived cells could be seen in the medial regions of the dentate gyrus too (Fig. 5A7-5A8 ). Graft-derived cells were only occasionally observed in the dentate SGZ-GCL. Quantification of the total numbers of graft-derived cells (i.e., CldUþ cells) demonstrated a yield that is equivalent to 28.0 6 9.2% of injected cells. Since 320,000 live cells with a CldU-labeling index of 91% were initially transplanted per hippocampus, 28% yield means that 81,536 new cells were added to each hippocampus with MGE-NSC grafting performed in this study.
Grafted MGE-NSCs Give Rise to Neurons, Astrocytes, Oligodendrocyte Progenitors, and GABA1 Neurons Grafted MGE-NSCs differentiated into NeuNþ neurons, GABAþ interneurons, astrocytes, and oligodendrocyte progenitors (Fig. 5C1-5F1 ). Among graft-derived cells, 13% differentiated into NeuNþ mature neurons, 57% into S-100bþ mature astrocytes and 3% into NG2þ oligodendrocyte progenitor cells (Fig. 5G1) . Moreover, 10% of graft-derived cells differentiated into GABA-ergic neurons (Fig. 5G1 ), indicating that a vast majority of neurons derived from grafts were GABAþ. Extrapolation of the yield of graft-derived cells with percentages of different cell types suggests that MGE-NSC grafting in this study resulted in addition of 10,600 new neurons, 46,476 new astrocytes, 2,446 new oligodendrocyte progenitors, and 8,154 new GABA-ergic neurons into each hippocampus of chronically epileptic rats.
Transplanted MGE-NSCs Give Rise to Substantial Numbers of New GDNF1 Cells
A fraction of cells derived from MGE-NSC grafts expressed GDNF, which morphologically appeared to be astrocytes (Fig.  6A1-6A4 ). Immunopositivity for GDNF was also found in Figure 2 . Differentiation of medial ganglionic eminence-neural stem cells (MGE-NSCs) after their dissociation from CldU-labeled neurospheres and incubation in the differentiation medium for 4 days (A1-D3) or 8 days (E1-F2). Differentiation of fractions of MGE-NSCs into TuJ-1þ neurons (A1, E1), O1þ oligodendrocytes (B1, F2), and GFAPþ astrocytes (C1, F1) could be seen at both time-points. Furthermore, fractions of MGE-NSCs also differentiate into GABA-ergic neurons [arrows in (D1-D3) and (E1, E2)]. Scale bar: 50 lm. The bar charts (G1, H1) illustrate percentages of MGE-NSCs that exhibit differentiation into TuJ-1þ neurons, GABAþ neurons, O1þ oligodendrocytes and GFAPþ astrocytes after incubation in the differentiation medium for 4 days (G1) or 8 days (H1). Note that the expression of GABA among TuJ-1þ neuronal population is 70% after 4 days and 50% after 8 days of incubation in the differentiation medium. Abbreviations: DAPI, 4 0 ,6-diamino-2-phenylindole; GABA, gamma-amino butyric acid; GFAP, glial fibrillary acidic protein.
graft-derived cells that migrated into different layers of the hippocampus. Quantification using CldU and GDNF dual immunofluorescence and confocal microscopic analyses revealed that 50% (mean 6 SEM ¼ 50.2 6 5.6) of graft-derived cells differentiated into cells expressing GDNF. Extrapolation of the yield of graft-derived cells with percentages of graftderived cells expressing GDNF suggested that MGE-NSC grafting resulted in addition of 40,768 new GDNFþ cells into each hippocampus of epileptic rats.
MGE-NSC Grafting Enhances the Fraction of GDNF1 Astrocytes in the Chronically Epileptic Hippocampus
We investigated whether seizure-suppressing effects of MGE-NSC grafting are linked to increased GDNF expression in the host hippocampus, as 50% of graft-derived cells expressed GDNF and previous studies have suggested that GDNF has anticonvulsant properties [22, 36] . Dual immunofluorescence Figure 3 . Long-term effects of MGE-NSC grafting (A-D) on SRMS in chronically epileptic rats. The y-axis in bar charts (A) and (C) denotes the average numbers of seizures per session (4-hour block) of observation. Note that MGE-NSC grafting considerably decreases the seizure frequency (A), the duration of individual seizures (B), the severity of seizures (C), and the total time spent in seizures (D). *, p < .05; **, p < .01. The bar charts in (E) and (F) show seizure frequency and seizure duration in chronically epileptic animals that received sham-grafting surgery. Sham-grafting surgery does not alter the seizure frequency or the seizure duration in chronically epileptic rats. Abbreviations: MGE, medial ganglionic eminence; NSC, neural stem cell; SRMS, spontaneous recurrent motor seizures.
for GDNF and S-100b in age-matched control animals revealed that virtually all GDNFþ cells in the hippocampus are S-100bþ, suggesting that GDNF is mostly found in the mature astrocytes (Fig. 6B1-6B3) . Quantification of cells that express GDNF among S-100bþ astrocytes revealed GDNF expression in 86% of astrocytes in the dentate gyrus, and CA1 and CA3 subfields (Fig. 6E1) . Similar analyses in rats with chronic epilepsy alone revealed substantial loss of GDNF expression in the S-100bþ astrocyte population (Fig.  6C1-6C3 , which was evidenced by GDNF expression in 42% of astrocytes in the dentate gyrus, and CA1 and CA3 subfields (p < .001 in comparison with control animals; Fig.  6E1 ). In contrast, rats with chronic epilepsy that received MGE-NSC grafts exhibited GDNF expression in 76% of S100bþ astrocytes in the dentate gyrus, and CA1 and CA3 subfields (p < .001 in comparison with rats with chronic epilepsy alone; Fig. 6E1 ). Thus, MGE-NSC grafting into the chronically epileptic hippocampus restores GDNF expression in S-100bþ astrocytes in different regions of the hippocampus. When compared with GDNF expression in the S-100bþ astrocyte population of age-matched control animals, this restoration appeared complete for the dentate gyrus (p > .05) but partial for the CA1 and CA3 subfields (p < .05 to p < .01; Fig. 6E1 ).
MGE-NSC Grafting Has No Effect on Neurogenesis in the Chronically Epileptic Hippocampus
We investigated the effects of MGE-NSC grafting on the status of hippocampal neurogenesis because of the likelihood that decreased hippocampal neurogenesis observed in chronic epilepsy partly underlies learning and memory impairments [5, 6, 37] . In comparison with an apparently normal distribution of newly born (DCXþ) neurons in the age-matched control hippocampus (Fig. 6F1 ), both epileptic groups (i.e., rats with chronic epilepsy alone and rats with chronic epilepsy plus MGE-NSC grafts) rarely showed DCXþ neurons along the antero-posterior extent of the hippocampus (Fig. 6G1,  6H1) . Furthermore, DCXþ neurons in both epileptic groups exhibited abnormal polarity with basal dendrites extending into the dentate hilus (Fig. 6G1, 6H1 ), in comparison with the characteristic growth of apical dendrites into the molecular layer observed in control rats (Fig. 6F1) . Quantification of numbers of DCXþ neurons in the dentate SGZ-GCL of Figure 4 . Comparison of data pertaining to learning and memory function using water maze test between age-matched controls and chronically epileptic rats both before and after MGE-NSC grafting. Age-matched controls (blue lines/bars) exhibit excellent spatial learning ability with progressive decreases in the latency to reach the platform over 11 sessions (A) and a dramatic reduction in the latency to reach the platform between the first and last sessions of learning (B). Before grafting, chronically epileptic rats though impaired in comparison with control rats show some ability for learning [red lines/bars in (A, B) ], which however worsens after grafting [green lines/bars in (A, B) ]. Figures (C-F) compare results of probe (memory retention) test performed at 24 hours after the last learning session in the three groups. Note that control rats score well for all parameters of memory retention (latency to reach the platform area, platform area crossings, dwell time in platform area, and dwell time in the platform quadrant). In contrast, chronically epileptic rats exhibit inability for memory retention both before and after MGE-NSC grafting, suggesting that MGE-NSC grafting does not alleviate learning and memory impairments prevailing in chronic epilepsy. Abbreviations: MGE, medial ganglionic eminence; NSC, neural stem cell. with respect to hippocampal cell layers and subfields in a chronically epileptic rat. These tracings, performed using the Neurolucida software (Microbrightfield Inc), represent every 10th 30-lm thick section through a chronically epileptic hippocampus that received four MGE-NSC grafts. Note that grafts and graft-derived cells were mostly located in the CA3 subfield and lateral ends of the CA1 subfield and the dentate gyrus. The core of transplants partially projected ventrally into the thalamus only at certain levels. The figures (B1-B3) illustrate the distribution of CldUþ graftderived cells in the host hippocampus. (B2) is a magnified view of a region from (B1) and (B3) is an enlarged view of a region from (B2). Both (B2) and (B3) show engraftment of graft-derived cells into SO, SP, and SR of the CA3 subfield. Scale bar: (A1-A11) 1,000 lm; (B1) 500 lm; (B2) 200 lm; (B3) 100 lm. Figures (C1-F1) illustrates differentiation of MGE-NSC graft-derived CldUþ cells into NeuNþ mature neurons (C1), S100bþ mature astrocytes (D1), NG2þ oligodendrocyte precursors (E1), and GABAþ neurons (F1), visualized through dual immunolabeling for CldU (red) and markers of neurons/glia (green) and Z-section analyses in a confocal microscope. Scale bar: (C1-E1) 20 lm; (F1) 10 lm; orthogonal inset of (F1) 5 lm. The bar chart in (G1) depicts the percentages of graft-derived cells that differentiate into NeuNþ neurons, GABAþ neurons, S100bþ astrocytes, and NG2þ oligodendrocyte precursors. Abbreviations: CldU, chlorodeoxyuridine; GABA, gamma-amino butyric acid; SO, strata oriens; SP, strata pyramidale; SR, strata radiatum. different groups revealed no effects of MGE-NSC grafting on hippocampal neurogenesis in chronically epileptic animals. In comparison with age-matched control animals, the overall decrease in hippocampal neurogenesis was 93% in rats with chronic epilepsy alone and 97% in chronically epileptic rats that received MGE-NSC grafts (p < .001; Fig. 6I1 ). Thus, MGE-NSC grafting did not improve hippocampal neurogenesis in chronically epileptic rats.
DISCUSSION
This study provides the first evidence that MGE-NSC grafting into the hippocampus is an effective approach for suppressing SRMS in chronic TLE. Animals that were chronically epileptic for prolonged periods exhibited considerable reductions in seizure frequency, duration and severity, and the amount of Figure 6 . Expression of GDNF in cells derived from MGE-NSC grafts (A1-A4), and MGE-NSC grafting mediated changes in GDNF expression of host hippocampal astrocytes (B1-E1) and hippocampal neurogenesis (F1-I1). Arrows in figures (A1-A3) show examples of graft-derived CldUþ cells (red) that express GDNF (green). (A4) shows orthogonal views of a GDNFþ graft derived cell (with CldUþ red nucleus and GDNFþ green cytoplasm). Scale bar: (A1-A3) 40 lm; (A4) 5 lm. Figures (B1-D3) show confocal microscopic images of S-100bþ hippocampal astrocytes (red) that exhibit GDNF expression (green) in an age-matched control rat (B1-B3), a rat with chronic epilepsy alone (C1-C3) and a chronically epileptic rat that received MGE-NSC grafts (D1-D3). The insets in (B3), (C3), and (D3) show orthogonal views of cells indicated by arrows. Note that these cells are positive for both S-100b and GDNF. Arrowheads in (C1) and (C3) denote S-100bþ astrocytes that lack GDNF expression in the epilepsy alone group. Scale bar: (B1-D3) 10 lm. The bar chart in (E1) shows percentages of S-100bþ astrocytes expressing GDNF in the dentate gyrus, and CA1 and CA3 subfields of the hippocampus in different groups. Note that GDNF expression in astrocytes declines substantially with chronic epilepsy in all regions of the hippocampus but recovers dramatically after MGE-NSC grafting. Figures (F1-H1) illustrates examples of newly born (doublecortinþ) neurons in the dentate gyrus in the three groups. Newly born neurons in the rat with chronic epilepsy alone (G1) and the chronically epileptic rat that received MGE-NSC grafts (H1) exhibit abnormal polarity and basal dendrites, in comparison with normal orientation of dendrites in newly born neurons of the age-matched control rat (F1). Scale bar: (F1-H1) 25 lm. The bar chart in (I1) compares numbers of newly born neurons between the three groups. Note that rats with chronic epilepsy alone (red) and chronically epileptic rats that received MGE-NSC grafts (green) exhibit greatly declined hippocampal neurogenesis compared with age-matched control rats (blue). Abbreviations: DCX, doublecortin; DH, dentate hilus; GCL, granule cell layer; GDNF, glial-derived neurotrophic factor; MGE, medial ganglionic eminence; NSC, neural stem cell; SGZ, subgranular zone.
time spent in seizures at 1-3 months after grafting of MGENSCs. Furthermore, MGE-NSC grafting caused addition of 8,154 GABA-ergic neurons and 40,768 GDNFþ cells into each hippocampus of epileptic animals. Moreover, MGE-NSC grafting restored GDNF expression in a vast majority of hippocampal astrocytes. Considering the inhibitory function of GABA-ergic neurons in synaptic transmission and antiepileptic properties of GDNF, it is likely that addition of new GABA-ergic neurons and GDNFþ cells, and restoration of GDNF in host hippocampal astrocytes underlie seizure suppression mediated by MGE-NSC grafting. Additionally, despite the restraint on SRMS, MGE-NSC grafting did not improve cognitive function in epileptic animals, which might be attributable at least partially to the failure of grafts to normalize the waned neurogenesis in the chronically epileptic hippocampus for prolonged periods.
Significance of the Animal Prototype and the Choice of Donor NSCs
Studies on NSC grafts in epilepsy models conducted so far used grafting as a pretreatment strategy for preventing chronic epilepsy development after acute seizures [38] [39] [40] [41] [42] [43] [44] [45] . Although such studies are needed for unraveling antiepileptogenic effects of NSC grafts, they are not germane to treating people afflicted with chronic TLE. As patients with drug-resistant epilepsy are the most likely candidates for NSC grafting therapy among the epilepsy patient population as an alternative to hippocampal resection, we chose rats that were epileptic for prolonged periods. As seizures in TLE mainly originate from the hippocampus and are associated with cognitive impairments and reduced hippocampal neurogenesis [3] [4] [5] [6] [7] , we tested the effects of bilateral grafting of NSCs into hippocampi of rats that were not only chronically epileptic but also had cognitive impairments. The choice of MGE-NSCs as donor cells in this study was based on several properties of MGE cells. As MGE is the source of all hippocampal GABA-ergic interneurons in the developing brain, we presumed that MGENSCs exhibit a high propensity for generating hippocampalspecific GABA-ergic interneurons after grafting. Furthermore, GABA-ergic interneurons derived from primary MGE cells have the ability for functional integration and increasing the extent of inhibition when grafted into the normal postnatal brain [23] .
Efficacy of MGE-NSC Grafts for Treating Spontaneous Seizures in Chronic TLE
This study provides several novel results regarding the efficacy of MGE-NSC grafts for treating chronic TLE. First, cells derived from MGE-NSC grafts exhibited ability for long-term survival and engraftment in the chronically epileptic hippocampus, as evidenced by 28% yield of injected cells after 3 months of grafting. The overall yield of graft-derived cells is better than the 10-20% yield of fetal MGE cells observed following grafting into the brain of normal/Kv1.1 mutant mice [16, 23] and 1% yield reported for SVZ-NSC grafts in a mouse model of epilepsy [46] . Second, most (73%) graftderived cells could be accounted by their differentiation into mature NeuNþ neurons, GABAþ neurons, S-100bþ mature astrocytes, or NG2þ oligodendrocyte precursors. Third, MGE-NSC grafts did not form tumors unlike the inclination of NSCs derived from embryonic stem cells for tumor formation [44] . More importantly, MGE-NSC grafting reduced the overall SRMS frequency by 43%, severity by 90%, and duration by 74%. These antiseizure effects appeared to be mediated by MGE-NSC grafts because sham-grafting surgery did not alter the frequency or intensity of SRMS in chronically epileptic rats.
Potential Mechanisms Underlying the SeizureSuppression Mediated by MGE-NSC Grafts
Our results suggest two potential mechanisms: addition of new GABA-ergic neurons, and addition of new GDNFþ cells with restoration of GDNF expression in hippocampal astrocytes. With regard to GABA-ergic neurons, MGE-NSC grafting resulted in addition of 8,154 GABA-ergic neurons into each hippocampus. This addition is substantial, considering the extent of GABA-ergic interneuron loss in chronic TLE [11, 12, 47, 48] . In light of the previous findings that grafting of cells that simply secrete GABA induces transient antiseizure effects [15, 18, 20, 49, 50] , one can surmise that the antiseizure effect is a consequence of increase in GABA concentration mediated by GABA-ergic neurons derived from grafts resulting in an increased threshold for the occurrence of SRMS. Nevertheless, since the antiseizure effect of grafts progressively improved over the postgrafting survival period and substantial numbers of graft-derived GABA-ergic neurons could be recovered after 3 months of grafting, inhibitory synaptic integration of graft-derived GABA-ergic neurons on hippocampal principal excitatory neurons cannot be ruled out. Indeed, previous studies on primary MGE cell grafts have demonstrated that axons of graft-derived GABA-ergic neurons integrate with the host brain circuitry and increase the level of inhibition [16, 23] . Thus, seizure-suppression in this study is likely mediated at least partially by the incorporation of graft-derived GABA-ergic neurons into the inhibitory hippocampal circuitry. Electrophysiological and electron-microscopic studies are needed in future to confirm this possibility however.
Pertaining to GDNFþ cells, MGE-NSC grafting resulted in addition of 40,768 new GDNFþ cells into each hippocampus of epileptic animals. Furthermore, MGE-NSC grafting induced GDNF expression in a vast majority (76%) of hippocampal astrocytes. Because this level of expression is closer to that of age-matched controls (GDNF in 86% of astrocytes) and substantially higher than that observed in animals with chronic epilepsy alone (GDNF in 42% of astrocytes), the restoration of GDNF levels after MGE-NSC grafting is apparent. Addition of new GDNFþ cells and restoration of GDNF expression in hippocampal astrocytes have functional implications because of the antiepileptic effects of GDNF. These include seizure-suppressing effects with recombinant adeno-associated virus (rAAV)-GDNF when administered to the hippocampus either before or after kindling or during the self-sustained phase of SE, and suppression of generalized seizures with implantation of encapsulated cells that are genetically modified to produce GDNF into the hippocampus of kindled rats [22, 36] . Thus, seizure suppression after MGE-NSC grafting is likely also linked to addition of new GDNFsynthesizing cells as well as restoration of GDNF expression in hippocampal astrocytes.
Cognitive Function in Chronically Epileptic Rats After MGE-NSC Grafting
Transplantation of MGE-NSC grafts did not reverse the hippocampal-dependent spatial learning and memory deficits in chronically epileptic rats. Bearing in mind the importance of neurogenesis for the hippocampal-dependent learning and memory function [51] [52] [53] [54] , the lack of improvement might be attributable at least partially to the inability of grafts to induce hippocampal neurogenesis that almost shuts down in chronic epilepsy [5, 6, 37] . Indeed, no effects of MGE-NSC grafting were observed on neurogenesis in this study when examined after 3 months of grafting. Lack of graft-mediated effects on neurogenesis likely reflects insufficient engrafting of graftderived NSCs into the dentate SGZ [25] . This is because most graft-derived cells differentiated into neurons and glia and migration of graft-derived cells into the dentate SGZ-GCL was minimal. Although our study might have missed the possible flourish of neurogenesis occurring early after grafting (due to analyses at only a long-term time-point after grafting), the results nevertheless point out that MGE-NSC grafting does not normalize neurogenesis for prolonged periods. Another reason for lack of improvement in cognition is that virtually all neurons derived from MGE-NSC grafts differentiated into GABA-ergic neurons rather than giving rise to CA1/ CA3 pyramidal neurons to replenish the decline in CA1 and CA3 pyramidal cell layers. Thus, grafts did not appear to repair the disrupted hippocampal circuitry in terms of replacing the connectivity of lost CA1 and CA3 pyramidal neurons. Rather, grafts have likely reduced the excitatory activity of surviving principal neurons via increased inhibition mediated by the addition of new GABA-ergic neurons and GDNFþ cells, and restoration of GDNF in hippocampal astrocytes. Restoration of cognitive pathways might require grafting of NSCs that are capable of engrafting substantially into the dentate SGZ and/or cells that have the ability to differentiate into hippocampal pyramidal neurons and repair the disrupted circuitry [12, 33, 55] .
CONCLUSION AND FUTURE DIRECTIONS
Our results demonstrate that MGE-NSC grafting into the hippocampus has great promise for treating chronic TLE, particularly for seizure control. However, several issues need to be resolved before its clinical application. These include finding human NSCs that are comparable with rat MGE-NSCs, testing the ability of human NSC or embryonic stem cell-derived GABA-ergic neurons [56] for long-term survival, synaptic integration, and seizure suppression in chronically epileptic prototypes, and development of strategies that both increase the yield of NSC graft-derived GABA-ergic neurons and promote the engraftment of graft-derived NSCs into the dentate SGZ to restore hippocampal neurogenesis, and analyses of transplants at multiple time points to account for depreciation of graft-derived cells with time.
